FDA
-
-
-
-
-
-
-
Adaptive Biotechnologies (ADPT) and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
-
-
-
-
-
-
-
NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer
-
-
-
-
-
-
-
NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023
-
-
-
-
-
-
-
NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch
-
-
-
-
-
-
-
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
-
-
-
-
-
-
-
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/01: (NEO) (SPWR) (MRK) Higher; (OMER) (IRNT) Lower (more...)
-
334,272 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


